CPDD 78th Annual Scientific Meeting Program

Monday, June 13, 2016
7 Marijuana use frequency is associated with viral load suppression and biobehavioral outcomes
in HIV+ patients
L. H. Lundahl 1 , C. L. Arfken 1 , J. A. Cohn 2 , M. Greenwald 1 , 1 Psychiatry and Behavioral
Neuroscience, Wayne State University School of Medicine, Detroit, MI, 2 Internal Med, Wayne
State University, Detroit, MI
8 Effects of HIV infection and cocaine dependence on laboratory-based decision making task
performance
S. L. Towe, A. L. Hobkirk, C. S. Meade, Psychiatry & Behavioral Sciences, Duke University,
Durham, NC
9 The interaction between cocaine dependence and HIV infection on risky decision making and its
neural substrates
M. Addicott, A. L. Hobkirk, D. Cordero, C. S. Meade, Psychiatry & Behavioral Sciences,
Duke University, Durham, NC
10 Is TAAR1 a potential therapeutic target for immune dysregulation in drug addiction?
L. M. Fleischer, N. Tamashunas, G. M. Miller, Pharmaceutical Sciences, Northeastern
University, Boston, MA
11 Development of a combination heroin-HIV vaccine
G. R. Matyas 1 , O. Torres 2 , R. Jalah 2 , J. Antoline 3,4 , K. K. Peachman 2 , M. Rao 1 , A. Jacobson 3,4 ,
C. Alving 1 , K. Rice 3,4 , 1 US Military HIV Research Program, Walter Reed Army Institute
of Research, Silver Spring, MD, 2 US Military HIV Research Program, Henry M. Jackson
Foundation, Silver Spring, MD, 3 NIDA, NIH, Bethesda, MD, 4 NIAAA, NIH, Bethesda, MD
12 HIV-1 Tat-protein elevates forebrain glutathione levels and increases morphine drug-seeking
and depression-like behaviors in mice
J. P. McLaughlin 2 , S. Eans 2 , J. Medina 2 , K. Hymel 2 , A. Rock 3 , D. Mintzopoulos 3 ,
M. J. Kaufman 1 , 1 Brain Imaging Center, McLean Hospital, Belmont, MA,
2
Pharmacodynamics, University of Florida, Gainesville, FL, 3 McLean Imaging Center,
McLean Hospital, Belmont, MA
PRECLINICAL STUDIES
13 Search for novel TLR4 antagonists for the treatment of neuropathic pain and drug abuse
M. Wang, A. E. Jacobson, Molecular Targets and Medications Discovery Branch, National
Institute of Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, Bethesda, MD
14 Morphine-induced analgesia in the sensory and affective components of inflammatory pain
A. Armendariz, A. Nazarian, Pharmaceutical Sciences, Western University of Health
Sciences, Pomona, CA
15 Partial kappa opioid receptor agonist effects in vivo in mice: Biased versus unbiased
C. Guariglia, A. Dunn, K. Windisch, E. Butelman, B. Reed, M. Kreek, The Rockefeller
University, New York, NY
16 Abuse-related effects of the biased mu opioid receptor agonist TRV130 on intracranial
self-stimulation in rats
A. Altarifi 1 , B. Blough 3 , S. S. Negus 2 , 1 Pharmacology, Jordan University of Science &
Technology, Irbid, Jordan, 2 Virginia Commonwealth University, Richmond, VA, 3 Research
Triangle Institute, Research Triangle Park, NC
12